文献速递临床微生物质量管理与危急值

犬源大肠埃希菌头孢噻呋兽医专用折点研究

Veterinary-specific breakpoints for ceftiofur applicable to canine Escherichia coli.
PubMed 文献 · J Clin Microbiol · 2026-07-27

本研究旨在建立犬源大肠埃希菌对头孢噻呋的药敏试验判读折点。通过耐药表型确定野生型折点(COWT)为1 μg/mL,PK-PD分析得COPD为0.25 μg/mL,犬膀胱炎试验得COCL为2 μg/mL。据此提出尿路感染MIC折点:≤1 μg/mL敏感、2 μg/mL中介、≥4 μg/mL耐药,以及纸片扩散法折点和非尿液全身感染折点。

要点

  • 犬尿路感染头孢噻呋MIC折点:≤1 μg/mL敏感、2 μg/mL中介、≥4 μg/mL耐药。
  • 纸片扩散法折点:≥23 mm敏感、20-22 mm中介、≤19 mm耐药。
  • 非尿液全身感染折点:≤0.125 μg/mL敏感、0.25 μg/mL中介、≥0.5 μg/mL耐药。

核心结论

  • 研究提出了犬源大肠埃希菌对头孢噻呋的兽医专用折点,涵盖尿路感染和非尿液全身感染。

研究设计与样本

  • 基于耐药表型确定野生型折点COWT,通过PK-PD分析和蒙特卡洛模拟推导COPD,并通过犬膀胱炎试验确定COCL。

主要发现

  • COWT为1 μg/mL,COPD为0.25 μg/mL,COCL为2 μg/mL。
  • 尿路感染MIC折点:≤1 μg/mL敏感、2 μg/mL中介、≥4 μg/mL耐药。
  • 纸片扩散法折点:≥23 mm敏感、20-22 mm中介、≤19 mm耐药。
  • 非尿液全身感染折点:≤0.125 μg/mL敏感、0.25 μg/mL中介、≥0.5 μg/mL耐药。

关键数值与推荐

  • 尿路感染MIC判读:敏感≤1 μg/mL,中介2 μg/mL,耐药≥4 μg/mL。
  • 纸片扩散法判读:敏感≥23 mm,中介20-22 mm,耐药≤19 mm。
  • 非尿液全身感染MIC判读:敏感≤0.125 μg/mL,中介0.25 μg/mL,耐药≥0.5 μg/mL。

临床怎么用

  • 诊断实验室可采用上述折点对犬源大肠埃希菌头孢噻呋药敏结果进行一致判读。
  • 兽医可依据折点指导犬尿路感染及全身感染的头孢噻呋治疗决策。
  • 折点可为耐药监测提供可靠依据,支持抗菌药物管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ceftiofur is a third-generation cephalosporin approved for veterinary applications and is used to treat Escherichia coli infections in dogs, particularly urinary tract infections (UTIs), in countries including China. Despite this use, there are no approved breakpoints for interpretation of ceftiofur susceptibility testing results. This absence limits the guidance that veterinarians need to effectively prescribe ceftiofur in dogs. It also limits the analysis of data from resistance monitoring and surveillance programs. This study aimed to establish ceftiofur interpretive categories and breakpoints that can be used to assess antimicrobial susceptibility testing results for canine E. coli isolates. Our methods included a definition of the wild-type cutoff (COWT) based on resistance phenotypes from two sources, deriving the pharmacokinetics/pharmacodynamics (PK-PD) cutoff (COPD) through PK-PD analyses and Monte Carlo simulations and determining the clinical cutoff (COCL) from a trial in dogs. Minimal inhibitory concentration (MIC) data were collected from China and the European database (European Committee on Antimicrobial Susceptibility Testing [EUCAST]). COWT was determined as 1 μg/mL. The COPD was 0.25 μg/mL. Through a canine cystitis trial, a COCL of 2 μg/mL was determined. Based on these findings and Clinical and Laboratory Standards Institute (CLSI)-recommended methods, we propose urinary tract infection-specific MIC breakpoints of ≤1 µg/mL (susceptible), 2 μg/mL (intermediate), and ≥4 µg/mL (resistant) and corresponding disk diffusion zone diameter breakpoints, determined by the error rate-bounded (ERB) method, of ≥23 mm (susceptible), 20-22 mm (intermediate), and ≤19 mm (resistant). The systemic breakpoints (non-urine) were determined to be ≤0.125 µg/mL (susceptible), 0.25 μg/mL (intermediate), and ≥0.5 µg/mL (resistant).IMPORTANCECeftiofur can be legally used, but laboratories and veterinarians lack canine-specific breakpoints to determine whether an isolate is susceptible or resistant. Without such criteria, test results can be inconsistent, treatment choices uncertain, and early signs of emerging resistance overlooked. This study fills that gap by defining evidence-based, canine-specific breakpoints for ceftiofur, particularly for urinary tract infections (UTIs). Adoption of these breakpoints will allow more consistent reporting by diagnostic laboratories, improve therapeutic decision-making for veterinarians, and provide a reliable basis for resistance surveillance. These advances strengthen the One-Health antimicrobial stewardship and help preserve the effectiveness of important antimicrobials for companion animals and the wider community.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Dang X, Chen S, Lyu H, et al. Veterinary-specific breakpoints for ceftiofur applicable to canine Escherichia coli. J Clin Microbiol. 2026. PMID: 42506934. doi:10.1128/jcm.00299-26

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。